MJFF announced an exciting second study to test Nilotinib ( The approved drug used for Cronic Myelogenous leukemia), repurposed for people with Parkinson's. This study is called Nilo-PD. It's restricted to the USA, they're looking for 75 PEOPLE with Parkinson's, between the ages of 40 to 79, who have moderate to advanced PD (Diagnosed five+ years).
To find out if you qualify and would like to participate log into Fox Trial Finder foxtrialfinder.michaeljfox.com
Tell them Toni referred you.
I fail to see what's so charming about a drug that costs $12,000 for 28 capsules in the US:
Great question! Nilo has not been approved for PD. If you're comparing it to Leukemia, the doses are far greater, therefore, more expensive. The first study Nilo reduced the buildup of alpha - synuclein. The Nilo-PD study would cost you $0. For more information contact Fox Trial Finder.
does anyone tries Nilotinib?
During the study, yes! the distribution will be (1-1-1 150 mg, 300 mg, placebo). Contact Fox Trial Finder to learn more.
New link found between PD & Melanoma
Air pollution is linked to PD
If Metformin can reverse aging it makes sense that it could reverse PD, but studies have shown increased risk. Puzzled Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PDHigh uric acid diet for PD?
